We next sought to understand the drivers and barriers to the adoption of AI-guided image analysis (also referred to as computational pathology or CP). The top value proposition for AI-guided analysis is to enable biomarker detection that is difficult or impossible to score manually, such as PD-L1 (Figure 3).